CACEIS has been selected to service the new MED Platform I fund run by ArchiMed, a private equity firm focusing on the healthcare industries.
The mandate covers depositary bank, custody, middle-office, fund accounting and financing services for the mid-market buy-and-build fund, MED Platform I fund.
MED Platform I, which held a final closing on 31 July at a hard cap of €1 billion, has attracted a range of institutional investors and family offices across Europe and North America.
The fund targets growth companies in the European and North American mid-cap healthcare industries and provides the strategic, tactical and financial resources required to extend product lines and expand into new regions.
Denis Ribon, founding partner of ArchiMed, stated: “Since winning the mandate for our second small-cap fund mandate in 2017, CACEIS’ private equity team has proven to be a reliable servicing partner, demonstrating its ability to deliver the comprehensive set of services we need.”
Ribon continued: “By supporting our first two small-cap funds, and our progression to the mid-cap space, CACEIS has become a key partner in administering the €1.7 billion under our management.”
Arnaud Garel-Galais, group head of private equity, real estate and securitisation, coverage and business development at CACEIS, commented: “We have a detailed understanding of ArchiMed’s needs and have adapted and developed our services to meet their ongoing requirements. Furthermore, we are proud to service a fund with several portfolio companies that are playing a major role in tackling the COVID-19 pandemic.”
